Microbiology · MU Sofia

100. Human Hepatitis Viruses: A, B, C, D, E, G

Covers the six human hepatitis viruses A, B, C, D, E and G, starting with a comparison table of genome type, family, envelope, transmission and chronicity. It then takes each virus in turn, covering its biology, transmission, incubation, clinical course, serological diagnosis, prevention and treatment, with the HBV serology markers set out separately and the HDV coinfection and superinfection distinction noted.

Inside: 8 sections · 5 labelled pictures · 1 table · 15 flashcards · 3 min

Topic 100 of 113 in the MU Sofia syllabus for Microbiology (Medicine, Year 3). The free AceMed note covers it in 8 sections, about 291 words (3 min of reading), with 15 flashcards.

In this note

  1. Human Hepatitis Viruses: A, B, C, D, E, G
  2. I. Overview of Hepatitis Viruses
  3. Hepatitis A Virus (HAV)
  4. Hepatitis B Virus (HBV)
  5. Hepatitis C Virus (HCV)
  6. Hepatitis D Virus (HDV)
  7. Hepatitis E Virus (HEV)
  8. Hepatitis G Virus (HGV / GBV-C)

Hepatitis A Virus (HAV)

  • RNA virus, non-enveloped, from Picornaviridae
  • Stable in environment; resistant to heat and acid
  • Transmitted via fecal-oral route (contaminated water/food)
  • Short incubation: 2–6 weeks
  • Clinical course:
  • Self-limiting acute hepatitis
  • No chronicity
  • Fever, malaise, anorexia → jaundice, hepatomegaly
  • Diagnosis: anti-HAV IgM (acute), IgG (past infection or vaccine)
  • Prevention: Inactivated vaccine, hygiene

Hepatitis B Virus (HBV)

  • Partially double-stranded DNA virus, enveloped
  • Unique reverse transcriptase activity (but is a DNA virus)
  • Transmission: blood, sexual contact, perinatal
  • Incubation: 4–12 weeks
  • Pathogenesis:
  • Damage is immune-mediated (CD8+ T cells attacking infected hepatocytes)
  • Can cause chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC)
  • Serology:
  • HBsAg = infection
  • anti-HBs = immunity
  • anti-HBc IgM = acute infection
  • anti-HBc IgG = prior exposure
  • HBeAg = active replication/high infectivity
  • Prevention:
  • Recombinant vaccine (HBsAg)
  • Neonatal prophylaxis: vaccine + HBIG
  • Treatment: Tenofovir, Entecavir, Peg-IFN-α

Hepatitis C Virus (HCV)

  • RNA virus, enveloped, from Flaviviridae
  • High genetic variability → no vaccine
  • Transmission: bloodborne (transfusions, IVDU, less sexual)
  • Incubation: 6–12 weeks
  • Frequently asymptomatic, but >80% become chronic
  • Long-term risks: chronic hepatitis, cirrhosis, HCC
  • Diagnosis: Anti-HCV Ab (screening), HCV RNA (confirmatory)
  • Treatment:
  • Direct-acting antivirals (DAAs) – e.g., Sofosbuvir + Velpatasvir
  • Curative in >95% cases

Continue reading free

The whole note, all 8 sections, is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.